Gilead Sciences, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 1 993
Quantité totale incluant filiales 3 271 (+ 1 278 pour les filiales)
Rang # Quantité totale PI 644
Note d'activité PI 3,7/5.0    1 114
Rang # Activité PI 660
Activité incl filiales 3,6/5.0    1 822
Symbole boursier
ISIN US3755581036
Capitalisation 114,800M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Services médicaux, services vété...

Brevets

Marques

857 143
279 52
580 25
57
 
Dernier brevet 2025 - Parp7 inhibitors
Premier brevet 1986 - 9-(phosponylmethoxyalkyl) adenin...
Dernière marque 2025 - CHOOSE U
Première marque 1989 - AMBISOME

Filiales

14 subsidiaries with IP (132 patents, 1146 trademarks)

8 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Promoting public awareness of testing, diagnosis, prevention, and treatment of HIV and AIDS
2024 P/S Promoting public awareness of environmental, social, and governance initiatives; business informa...
P/S Charitable foundation services, namely, providing financial assistance for programs and services ...
P/S Assisting patients in enrolling in pharmaceutical reimbursement programs of others
P/S Healthcare services; medical services; telemedicine services; providing medical information via a...
P/S Insurance information; insurance consultancy; providing counseling and consulting in the field of...
P/S Retail pharmacy services; online retail pharmacy services; pharmaceutical services, namely proces...
P/S Platform as a service featuring computer software platforms for requesting pharmacy products and ...
P/S Providing medical information regarding the prevention, treatment and diagnosis of HIV/AIDS
Invention Glp-1r modulating compounds. The present disclosure provides GLP-1R agonists, and compositions, ...
Invention Compounds and methods for treatment of viral infections. Compounds of Formula I, Formula A, or Fo...
Invention Methods and intermediates for preparing therapeutic compounds. The present disclosure relates to...
Invention Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds. Provided herein a...
Invention Solid forms of a nucleoside analogue and uses thereof. The disclosure provides solid forms, e.g....
Invention Kras g12d modulating compounds. Provided herein are compounds, and pharmaceutically acceptable s...
Invention Solid forms of a nucleoside analogue and uses thereof. The disclosure provides solid forms, e.g. ...
Invention Kras g12d modulating compounds. Provided herein are compounds, and pharmaceutically acceptable sa...
Invention Antiviral compounds and methods of making and using the same. Antiviral compounds and methods of...
Invention Antiviral compounds and methods of making and using the same. Antiviral compounds of formula I an...
Invention Solid forms of fxr agonists. Disclosed herein are novel solid forms of FXR agonists. The disclos...
Invention Antiviral compounds and methods of making and using the same. Antiviral compounds and methods of ...
Invention Dosing regimen of hiv capsid inhibitor. The present disclosure relates to dosing regimens of an ...
P/S providing grants to individuals, organizations, and programs in support of improving health and w...
Invention Treatment of non-small cell lung cancer using sacituzumab govitecan and an anti-pd-1 antibody or ...
Invention Pharmaceutical formulations of bictegravir and lenacapavir. The disclosure provides a solid oral...
Invention Pharmaceutical formulations of bictegravir and lenacapavir. The disclosure provides a solid oral ...
Invention Parp7 inhibitors. Provided herein is a compound of Formula I: Provided herein is a compound of...
Invention Weekly regimen for hiv. The present disclosure provides methods of treating or preventing human ...
Invention Parp7 inhibitors. Provided herein is a compound of Formula (I) or a pharmaceutically acceptable s...
Invention Parp7 inhibitors. Provided herein is a compound of Formula (I): Provided herein is a compound ...
Invention Parp7 inhibitors. Provided herein is a compound of Formula (I): or a pharmaceutically acceptable ...
Invention Methods of identifying hiv patients sensitive to therapy with gp120 v3 glycan-directed antibodies...
Invention Multi-specific antigen binding molecules targeting hiv and methods of use. Provided are multi-sp...
Invention Thienopyrrole compounds. The present disclosure relates generally to certain compounds, pharmace...
Invention Processes for making irak4 inhibitors. The present disclosure relates generally to processes for...
Invention Salts and solid forms of a compound that modulates irak4. The present disclosure relates to salt...
Invention Kras modulating compounds. Provided herein are compounds, and pharmaceutically acceptable salts ...
Invention Hiv inhibitor compounds. The invention provides a compound of Formula I: The invention provide...
Invention Solid forms. The present disclosure relates to crystalline and solvate forms of a nucleoside rev...
Invention Mk2 inhibitors and methods of making and using the same. The present disclosure relates generall...
Invention Antiviral compounds. The present disclosure provides a compound of Formula I: The present disc...
Invention Phospholipid compounds and methods of making and using the same. Phospholipid compounds and meth...
Invention Fxr (nr1h4) modulating compounds. The present disclosure relates generally to compounds that bin...
Invention Hiv vaccines and methods of using. Provided are HIV-1 fusion polypeptides, polynucleotides encod...
Invention Sars-cov2 main protease inhibitors. The present disclosure relates to compounds of Formula I: ...
Invention Quinoline derivatives. The present disclosure provides a compound of Formula (I): The present ...
Invention Therapeutic compounds for hiv. The present disclosure relates generally to certain compounds, ph...
Invention Process of preparing hiv capsid inhibitor. The present disclosure relates generally to processes...
Invention Anti-hiv compounds. The invention provides compounds having Formula (I): The invention provide...
P/S Providing online, non-downloadable interactive chatbot software for providing medical information...
Invention Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating...
P/S Pharmaceutical preparations.
Invention Nucleoside phosphoramidates. Disclosed herein are nucleoside phosphoramidates and their use as a...
P/S Providing online non-downloadable interactive chatbot software for providing medical information....
2023 P/S Providing online non-downloadable interactive chatbot software for providing medical information ...
P/S Charitable services, namely, providing financial grants to individuals, organizations and program...
P/S Downloadable podcasts in the field of healthcare, medical conditions and cancer treatment Providi...
P/S Promoting public awareness in the field of oncology, namely, medical and scientific research, tre...
Invention Dosing regimen of hiv capsid inhibitor. The present disclosure relates to dosing regimens of an H...
P/S downloadable computer software in the nature of mobile applications for tracking events and educa...
Invention Weekly regimen of lenacapavir for the treatment and prevention of hiv. The present disclosure pro...
P/S Downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, a...
Invention Blister pack
P/S Promoting public awareness about treatments and diagnosis in the field of oncology. Museum servic...
P/S Providing an internet website portal featuring technology that enables users to submit research g...
P/S Providing an internet website portal featuring technology that enables users to submit research ...
P/S Providing financial information regarding assistance with patient access to HIV treatment program...
P/S Educational services, namely events and seminars, in the field of oncology Providing medical info...
P/S Pharmaceutical products. Medical devices; surgical, medical, dental and veterinary apparatus and ...
2022 P/S Providing grants to individuals, organizations and programs in the field of oncology
P/S charitable services, namely, providing financial grants to individuals, organizations and program...
P/S Condoms
P/S Conducting programs, conferences, courses, tutorials and seminars regarding prevention, treatment...
P/S Conducting educational events, course, tutorials and seminars regarding prevention, treatment an...
P/S Promoting public awareness of medical treatment guidelines, clinical trial results, and disease p...
P/S Arranging and conducting of conferences, congresses and symposiums in the field of hiv; education...
P/S Education relating to pharmaceuticals, medical conditions, and medical treatments; providing of t...
P/S Providing medical information regarding diagnosis and treatment in the field of breast cancer; Pr...
P/S promoting public awareness of testing, diagnosis, prevention, and treatment of HIV and AIDS
2021 P/S Conducting educational seminars in the field of infectious diseases and dissemination of material...
P/S Providing grants for research, education and innovation in the field of HIV
P/S charitable services, namely, providing financial grants for to individuals, organizations and pro...
P/S providing grants to individuals, organizations and programs in support of improving health and we...
P/S Pharmaceutical preparations; Pharmaceutical preparations, namely, pharmaceuticals for the treatme...
2017 Invention Fxr (nr1h4) modulating compounds. The present disclosure relates generally to compounds which bin...